rodatristat ethyl   Click here for help

GtoPdb Ligand ID: 10646

Synonyms: compound 15b [PMID: 28041831] | KAR-5585 | KAR5585 | RVT-1201
Compound class: Synthetic organic
Comment: Rodatristat ethyl (KAR5585) is the inactive prodrug of rodatristat [1]. It is bioconverted in vivo by esterase activity.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 102.6
Molecular weight 589.21
XLogP 7.84
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES CCOC(=O)[C@H]1NCC2(C1)CCN(CC2)c1cc(nc(n1)N)O[C@@H](C(F)(F)F)c1ccc(cc1c1ccccc1)Cl
Isomeric SMILES CCOC(=O)[C@H]1NCC2(C1)CCN(CC2)c1cc(nc(n1)N)O[C@@H](C(F)(F)F)c1ccc(cc1c1ccccc1)Cl
InChI InChI=1S/C29H31ClF3N5O3/c1-2-40-26(39)22-16-28(17-35-22)10-12-38(13-11-28)23-15-24(37-27(34)36-23)41-25(29(31,32)33)20-9-8-19(30)14-21(20)18-6-4-3-5-7-18/h3-9,14-15,22,25,35H,2,10-13,16-17H2,1H3,(H2,34,36,37)/t22-,25+/m0/s1
InChI Key TZSZZENYCISATO-WIOPSUGQSA-N
No information available.
Summary of Clinical Use Click here for help
As rodatristat is administered as its prodrug rodatristat ethyl, clinical trials use the research codes of the prodrug (either KAR5585 or RVT-1201). We have curated clinical trial information against both rodatristat and rodatristat ethyl for user benefit. Clinical evauation of rodatristat in patients with pulmonary arterial hypertension (PAH) has advanced to Phase 2.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT03924154 A Study of RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1) Phase 2 Interventional Altavant Sciences GmbH